Boston Scientific (BSX) Short-term Investments (2019 - 2020)
Boston Scientific (BSX) posted quarterly Short-term Investments of $146.0 million for Q3 2020, down 9.32% on a QoQ basis from $161.0 million in Q2 2020.
Boston Scientific (BSX) Short-term Investments (2019 - 2020) Analysis & Trends
Boston Scientific has reported Short-term Investments for 2 years, with the latest figure at $146.0 million in Q3 2020.
- Short-term Investments for Q3 2020 came in at $146.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $146.0 million (changed N/A YoY), and the FY2019 annual result was $105.0 million, changed N/A from the prior year.
- Short-term Investments eased to $146.0 million in Q3 2020, from $161.0 million in the prior quarter.
- Over five years, Short-term Investments peaked at $218.0 million in Q1 2020 and troughed at $105.0 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 146.00 Mn |
| Jun 30, 2020 | 161.00 Mn |
| Mar 31, 2020 | 218.00 Mn |
| Dec 31, 2019 | 105.00 Mn |